Owned by the Association for International Promotion & Study in Tumors (APSIT)
Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
Mitochondrial fusion and fission proteins have been nominated as druggable targets in cancer. Whether their inhibition is efficacious in triple negative breast cancer (TNBC) that almost invariably develops che...